NanoGroup S.A. (WSE: NNG)
Poland
· Delayed Price · Currency is PLN 4.060
+0.120 (3.05%)
Sep 27, 2024, 5:00 PM CET
NanoGroup Company Description
NanoGroup S.A. operates as a biotechnology company in Poland.
The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies.
It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology.
The company was incorporated in 2016 and is based in Warsaw, Poland.
NanoGroup S.A.
| Country | Poland |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Przemyslaw Mazurek |
Contact Details
Address: ul. Rakowiecka 36 Warsaw, 02-532 Poland | |
| Phone | 48 604 74 13 03 |
| Website | nanogroup.eu |
Stock Details
| Ticker Symbol | NNG |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLNNGRP00011 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Przemyslaw Daniel Mazurek | President of the Management Board |
| Piotr Pietrzak | Vice President of the Management Board |
| Prof. Tomasz Adam Ciach | Founder and Member of the Management Board |
| Anna Redwan | Chief of Corporate Affairs and Communications |